The pharmacy landscape is undergoing a rapid transformation, and there’s no better vantage point to witness this evolution than the Asembia 2024 Conference. Set against the luxurious backdrop of Wynn & Encore Las Vegas, this pivotal event is poised to shape the future of the industry, drawing in a vibrant community of pharmaceutical professionals eager […]
Power of Pharmacy: Highlights from Asembia Conference 2024 Read More »
The world of specialty pharmaceuticals consistently brings forth groundbreaking therapies, bringing hope to patients suffering from previously incurable conditions. However, their success heavily depends on patient adherence. An in-depth examination of patient journeys indicates a concerning fact – a sizeable number of patients, prescribed these potentially life-saving specialty drugs, discontinue their treatment plans frequently before their
Patient Non-Adherence in Specialty Pharmaceuticals Unveiled Read More »
Navigating the patient treatment journey is like solving a complex puzzle for the pharmaceutical industry. At every turn, there are challenges, most notably the phenomenon of patient treatment abandonment. Imagine spending years developing a drug that could potentially save thousands of lives, only to find out that a significant portion of patients who should be
Understanding Why Patients Abandon Prescribed Treatments Read More »
Specialty pharmacists can help patients changing payers or providers, and specialty pharmacy data helps with medication adherence strategies.
Overcoming Challenges in Cell and Gene Therapy Read More »
Get ready for Hub and Specialty Pharmacy Models: East 2024 and join industry experts and top solution providers to learn about proven strategies and cutting-edge approaches to optimize performance and hub strategy. Explore the timely content and expert speaker lineup to help you maximize patient access and adherence. In the everchanging hub landscape, it has
Innovative Approaches: Hub and Specialty Pharmacy Models East 2024 Read More »
Specialty pharmacy distribution is changing as specialty drug treatments become more commonplace. Many biosimilars have entered the rare disease market, directly competing with biologics like Humira that represented breakthroughs in their time. New treatments for a wide range of conditions are also available, including biologics, cell and gene therapies for rare diseases. Wider adoption of
How Will Orphan Drugs Fare in an Era of Rising Costs and Wider Use? Read More »
Patients readily switch doctors, making medication adherence strategies difficult. Specialty pharmacy data can assist with the patient journey orchestration.
Enhancing Medication Adherence with Specialty Pharmacy Data Read More »
Specialty pharmacists can help patients changing payers or providers, and specialty pharmacy data helps with medication adherence strategies.
Specialty Pharmacy Data for Medication Adherence Read More »
A look at pharma market insights plus regulatory news updates from the FDA and related agencies to wrap up 2023.
2023 Wrap-Up: Regulatory Updates in Specialty Pharma Read More »
Cell and gene therapies in development today provide real world evidence analytics for how rare diseases will be treated tomorrow.
Real-World Evidence in Cell and Gene Therapies Read More »